Richard P. Lifton

Richard P. Lifton

Auto-generated profile, based on publicly available information

Richard P. Lifton

Laboratory of Human Genetics and Genomics, The Rockefeller University

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
QZQian Zhang
Qian Zhang
DMDaniela Matuozzo
Daniela Matuozzo
JPJérémie Le Pen
Jérémie Le Pen
DLDanyel Lee
Danyel Lee
LMLeen Moens
Leen Moens
JCJean-Laurent Casanova
Jean-Laurent Casanova
Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5–13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10−11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children.

19 September 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SVSílvia Vilarinho
Sílvia Vilarinho
SSSinan Sari
Sinan Sari
FMFrancesca Mazzacuva
Francesca Mazzacuva
KBKaya Bilgüvar
Kaya Bilgüvar
GEGüldal Esendagli-Yilmaz
Güldal Esendagli-Yilmaz
RLRichard P. Lifton
Richard P. Lifton
Significance: Liver disease of unknown cause represents an unmet medical need. Using exome sequencing, we describe a syndrome associated with homozygous loss of Acyl CoA Oxidase 2 ( ACOX2 ) featuring elevated transaminase levels, liver fibrosis, ataxia, and cognitive impairment. ACOX2 encodes the peroxisomal branched-chain acyl-CoA oxidase and is involved in the bile acid biosynthetic pathway. Importantly, this disorder is potentially reversible, because the bile acid synthetic pathway can be suppressed with exogenous bile acids, diminishing the production of the toxic metabolites likely causing liver and neurologic dysfunction. This study provides the means to diagnose ACOX2 deficiency in patients with chronic idiopathic liver disease and/or cryptogenic cirrhosis.

4 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KIKenichi Ishizawa
Kenichi Ishizawa
QWQin Wang
Qin Wang
JLJinping Li
Jinping Li
OYOsamu Yamazaki
Osamu Yamazaki
YTYoshifuru Tamura
Yoshifuru Tamura
SSShigeru Shibata
Shigeru Shibata
Significance: Calcineurin inhibitors (CNIs) are potent immunosuppressants; hypertension and hyperkalemia are common adverse effects. Activation of the renal Na-Cl cotransporter (NCC) is implicated in this toxicity; however, the mechanism is unknown. CNIs’ renal effects mimic the hypertension and hyperkalemia resulting from mutations in WNK kinases or in KLHL3-CUL3 ubiquitin ligase. WNKs activate NCC and are degraded by ubiquitylation upon their binding to KLHL3. The binding of WNKs to KLHL3 is prevented by KLHL3 mutations or by PKC-mediated KLHL3 phosphorylation at serine 433. This work shows that calcineurin dephosphorylates KLHL3 S433 , promoting WNK4 degradation. Conversely, CNIs inhibit KLHL3 S433 dephosphorylation, preventing WNK degradation. These findings implicate calcineurin in the normal regulation of KLHL3’s binding of WNK4 and identify a direct target causing CNI-induced pathology.

17 January 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MCMaria Castañeda-Bueno
Maria Castañeda-Bueno
JAJuan Pablo Arroyo
Juan Pablo Arroyo
JZJunhui Zhang
Junhui Zhang
JPJeremy Puthumana
Jeremy Puthumana
OYOrlando Yarborough
Orlando Yarborough
RLRichard P. Lifton
Richard P. Lifton
Significance: The kinase WNK4 (with-no-lysine kinase 4) is an important regulator of the Na-Cl cotransporter (NCC) in the renal distal convoluted tubule (DCT). Volume depletion induces angiotensin II, activating PKC, which prevents WNK4 degradation by phosphorylating the KLHL3/CUL3 ubiquitin ligase. We now show that PKC also directly phosphorylates WNK4 at multiple sites in cell culture. Phosphorylation of two of these sites, S64 and S1196, promotes increased WNK4 kinase activity by increasing autophosphorylation of the WNK4 T-loop at S332. Volume depletion also induces phosphorylation of WNK4-S64 in the DCT in vivo, promoting NCC activity. These findings provide insights into the mechanisms regulating activity of NCC and the promotion of renal Na-Cl reabsorption without concomitant K+secretion in volume depletion.

1 July 2018 in Cell Reports
Verified
Journal Article
Open access
SSShigeru Shibata
Shigeru Shibata
KIKenichi Ishizawa
Kenichi Ishizawa
QWQin Wang
Qin Wang
NXNing Xu
Ning Xu
TFToshiro Fujita
Toshiro Fujita
RLRichard P. Lifton
Richard P. Lifton
Mineralocorticoid receptor (MR) signaling regulates both renal Na-Cl reabsorption and K+ excretion. We previously demonstrated that phosphorylation of S843 in the MR ligand-binding domain in renal intercalated cells is involved in the balance of these activities by regulating ligand binding and signaling. However, the kinase that phosphorylates MRS843 is unknown. Using a high-throughput screen assay of 197 kinases, we found that ULK1 is the principal kinase that is responsible for the phosphorylation of MRS843. The results were confirmed by in vitro kinase assay, mass spectrometry, and siRNA knockdown experiments. Notably, phosphorylation at MRS843 was markedly reduced in ULK1/2 double knockout mouse embryonic fibroblasts. Upstream, we show that ULK1 activity is inhibited by phosphorylation induced by angiotensin II via mTOR in cell culture and in vivo. These findings implicate mTOR and ULK1 as regulators of MR activity in intercalated cells, a pathway that is critical for maintaining electrolyte homeostasis.

6 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KDKaela Drzewiecki
Kaela Drzewiecki
JCJungmin Choi
Jungmin Choi
JBJoseph Brancale
Joseph Brancale
MLMichael A. Leney-Greene
Michael A. Leney-Greene
SSSinan Sari
Sinan Sari
SVSílvia Vilarinho
Sílvia Vilarinho
Portal hypertension is a major contributor to decompensation and death from liver disease, a global health problem. Here, we demonstrate homozygous damaging mutations in GIMAP5, a small organellar GTPase, in four families with unexplained portal hypertension. We show that GIMAP5 is expressed in hepatic endothelial cells and that its loss in both humans and mice results in capillarization of liver sinusoidal endothelial cells (LSECs); this effect is also seen when GIMAP5 is selectively deleted in endothelial cells. Single-cell RNA-sequencing analysis in a GIMAP5-deficient mouse model reveals replacement of LSECs with capillarized endothelial cells, a reduction of macrovascular hepatic endothelial cells, and places GIMAP5 upstream of GATA4, a transcription factor required for LSEC specification. Thus, GIMAP5 is a critical regulator of liver endothelial cell homeostasis and, when absent, produces portal hypertension. These findings provide new insight into the pathogenesis of portal hypertension, a major contributor to morbidity and mortality from liver disease.